샘플 요청 목록

 카트 문의
시장보고서
상품코드
1579662

세계의 수의학 분자진단 시장

Veterinary Molecular Diagnostics
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 173 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

수의학 분자진단 세계 시장 규모는 2030년까지 9억 8,420만 달러에 달할 것으로 전망

2023년 5억 9,650만 달러로 추정되는 수의학 분자진단 세계 시장은 2023년부터 2030년까지 연평균 7.4% 성장하여 2030년에는 9억 8,420만 달러에 달할 것으로 예상됩니다. 본 보고서에서 분석한 부문 중 하나인 기기 및 소프트웨어는 CAGR 7.2%를 기록하여 분석 기간 종료 시점에 3억 4,280만 달러에 도달할 것으로 예상됩니다. 키트 및 시약 부문의 성장률은 분석 기간 동안 CAGR 8.3%로 추정됩니다.

미국 시장은 1억 5,670만 달러로 추정 및 예측, 중국은 CAGR 11.0%로 성장 전망

미국의 수의학 분자진단 시장은 2023년 1억 5,670만 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2030년까지 2억 3,890만 달러 규모에 도달할 것으로 예상되며, 2023-2030년간 11.0%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 3.9%와 6.6%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 유럽에서는 독일이 연평균 4.6%의 성장률을 보일 것으로 예상됩니다.

세계 수의학 분자진단 시장 - 주요 동향 및 시장 성장 촉진요인 살펴보기

수의학 분자진단학이 동물 건강관리에 혁명을 일으킬 수 있는 이유는 무엇인가?

수의학 분자진단은 분자 수준에서 정확하고 신속하게 질병을 감지할 수 있게 함으로써 동물 건강 관리의 혁신적인 도구로 등장했습니다. 그렇다면 왜 이런 진단법이 현대 수의학에 필수적인 것일까? 수의학 분자진단학은 동물의 병원체, 종양, 유전질환에서 DNA, RNA와 같은 유전물질을 식별하는 첨단 검사 기술입니다. 이러한 검사에는 중합효소연쇄반응(PCR), 실시간 PCR, 차세대염기서열분석(NGS), 마이크로어레이 등이 있으며, 병원체, 유전자 돌연변이, 바이오마커를 높은 민감도와 특이성으로 검출하고 정량화할 수 있습니다. 질병의 유전적 기반을 표적으로 삼는 이러한 진단은 수의사가 임상 증상이 나타나기 전에 질병을 조기에 진단하여 적시에 개입하고 치료할 수 있는 중요한 창구를 제공할 수 있습니다.

수의학 분자진단에 대한 수요는 인수공통전염병의 확산, 동물의 만성 및 전염성 질환의 발생률 증가, 예방적 건강관리에 대한 관심 증가에 의해 주도되고 있습니다. 이러한 진단은 파보바이러스, 고양이 백혈병, 소 호흡기 질환과 같은 감염성 질환의 검출과 유전성 질환의 전염을 예방하기 위한 번식 프로그램의 유전자 검사에 널리 사용되고 있습니다. 분자진단학은 암 치료를 위한 표적 치료의 지침이 되는 특정 돌연변이 및 바이오마커를 식별하는 데 사용되고 있습니다. 또한, 분자진단은 친척 병원체를 구별하고 한 번의 검사로 여러 병원체를 검출할 수 있기 때문에 기존의 검사 방법으로는 충분하지 않은 복잡한 사례에서 선호되는 선택이 되고 있습니다. 반려동물 보호자, 가축 관리자 및 수의사가 보다 정확하고 신뢰할 수 있는 진단 솔루션을 요구함에 따라 수의학 분자진단은 동물 건강 관리에서 점점 더 중심적인 역할을 하게 될 것입니다.

기술의 발전은 수의학 분자진단의 성능을 어떻게 향상시키고 있는가?

수의학 분자진단 시장은 이러한 진단 도구의 정확성, 속도, 접근성을 향상시키는 중요한 기술 발전을 경험했습니다. 그렇다면 이러한 발전의 원동력이 된 주요 기술 혁신은 무엇일까요? 가장 영향력 있는 발전 중 하나는 실시간 PCR(qPCR) 기술의 발전입니다. qPCR은 실시간으로 DNA 또는 RNA 서열을 증폭하고 정량화할 수 있는 능력으로 신속하고 민감한 결과를 제공함으로써 동물 진단의 표준이 되었습니다. 최신 qPCR 시스템은 멀티플렉스 기능을 갖추고 있어 하나의 샘플에서 여러 병원체 및 유전자 마커를 동시에 검출할 수 있습니다. 이러한 기술 혁신으로 인해 검사 시간이 크게 단축되고, 여러 번 검사할 필요가 없어져 수의사가 보다 신속하고 정확한 판단을 내릴 수 있게 되었습니다. 또한 자동 시료 준비 시스템의 통합은 워크플로우를 간소화하고 인적 오류의 가능성을 줄여 검사 결과의 일관성과 신뢰성을 향상시켰습니다.

또 다른 중요한 혁신은 차세대 시퀀싱(NGS) 기술의 등장으로 수의학 유전체학 분야에 혁명을 일으켰으며, NGS는 전체 유전체이나 특정 영역의 염기서열을 결정함으로써 종합적인 유전자 분석이 가능해져 복잡한 유전형질, 질병 메커니즘, 미생물 군집에 대한 통찰력을 얻을 수 있습니다. 메커니즘, 미생물 군집에 대한 통찰력을 얻을 수 있습니다. 이 기술은 병원체 발견, 항균제 내성 모니터링, 암 유전자형 분석 등 연구 및 임상에서 점점 더 많이 사용되고 있습니다. 휴대용 및 현장 진료형 분자진단 장비의 개발로 이러한 기술의 활용 범위가 더욱 확대되어 수의사가 진료소, 농장, 현장 등 현장에서 검사를 실시할 수 있게 되었습니다. 이러한 장비는 사용자 친화적으로 설계되어 최소한의 교육이나 인프라가 필요하기 때문에 원격지나 자원이 제한된 환경에서도 고급 분자진단에 접근할 수 있습니다. 또한, 생물정보학 및 데이터 분석의 발전은 분자진단 결과의 해석을 강화하여 보다 정확하고 실용적인 통찰력을 제공합니다. 이러한 기술 혁신은 수의학 분자진단의 성능과 실용성을 향상시켜 현대 수의학에 필수적인 도구로 자리매김하고 있습니다.

동물 건강관리에서 수의학 분자진단의 보급을 촉진하는 시장 동향은 무엇인가?

수의사, 연구자, 보호자의 진화하는 요구와 기대를 반영하여 몇 가지 새로운 시장 트렌드가 동물 건강 관리 분야에서 수의학 분자진단의 채택을 형성하고 있습니다. 가장 두드러진 트렌드 중 하나는 예방 의료와 질병 조기 발견에 대한 관심이 높아지고 있다는 점입니다. 반려동물 보호자와 가축 관리자들이 조기 진단의 이점을 더 많이 인식함에 따라, 질병이 증상이 나타나거나 다른 동물에게 전염되기 전에 무증상 단계에서 질병을 감지할 수 있는 진단 도구에 대한 수요가 증가하고 있습니다. 높은 민감도와 특이성을 가진 수의학 분자진단은 이러한 목적에 적합하며, 감염성 병원체, 유전적 질환, 암세포를 조기에 식별할 수 있습니다. 이러한 추세는 정기적인 건강검진과 웰니스 프로그램이 보편화되고 있는 반려동물 분야에서 특히 두드러지게 나타나고 있습니다. 유전적 소인과 감염을 조기에 발견할 수 있는 능력은 수의사가 맞춤형 예방 조치를 시행하고 맞춤 치료 계획을 수립할 수 있게 함으로써 건강 상태를 개선하고 장기적으로 치료 비용을 절감할 수 있게 합니다.

수의학 분자진단의 도입을 촉진하는 또 다른 중요한 추세는 인수공통전염병 증가와 효과적인 질병 감시의 필요성입니다. 동물과 사람 사이에 전염되는 인수공통전염병은 공중보건상 심각한 위험이며, 발생을 억제하고 종간 전파를 막기 위해서는 조기에 정확한 진단이 필수적이며, 코로나19의 대유행은 강력한 질병 감시 시스템의 중요성을 강조하고 있으며, 반려동물과 가축의 진단 인프라에 대한 투자 확대로 이어졌습니다. 수의학 분자진단은 수의학 분자진단은 인수공통전염병 병원체를 신속하고 정확하게 탐지할 수 있는 도구를 제공함으로써 질병 확산을 추적하고 통제하기 위한 노력을 지원하는 데 중요한 역할을 하고 있습니다. 이러한 추세는 북미와 유럽 등 가축이 많은 지역에서 특히 두드러지게 나타나고 있으며, 조류 인플루엔자, 소 결핵, 아프리카돼지열병 등의 질병을 감시하는 데 분자진단이 활용되고 있습니다. 종합적인 질병 감시 및 바이오 보안 조치에 대한 수요가 증가함에 따라 민관 부문 모두에서 분자진단의 채택을 지속적으로 촉진하고 동물 건강 관리의 중요한 수단으로서의 역할을 강화할 것으로 예상됩니다.

수의학 분자진단 세계 시장 성장 촉진요인은?

세계 수의학 분자진단 시장의 성장은 진단 기술의 발전, 동물 건강 관리에 대한 투자 증가, 인수공통전염병에 대한 인식 증가 등 여러 가지 요인에 의해 주도되고 있습니다. 주요 성장 요인 중 하나는 반려동물 인구 증가와 반려동물의 인간화이며, 반려동물 보호자들은 동물을 가족의 일원으로 여기고 고급 의료 서비스에 기꺼이 투자하고 있습니다. 이에 따라 신속하고 정확한 결과를 제공하여 조기 진단과 효과적인 치료를 가능하게 하는 진단 검사에 대한 수요가 급증하고 있습니다. 사용자 친화적이고 자동화된 분자진단 플랫폼의 개발로 동물병원 및 클리닉은 이러한 검사를 일상적인 진단 업무에 쉽게 통합할 수 있게 되어 시장 성장에 더욱 박차를 가할 수 있게 되었습니다. 농가와 생산자들이 가축의 건강, 생산성 및 질병 관리를 개선하기 위해 노력하면서 가축 관리에서 분자진단의 사용이 증가하고 있는 것도 주요 촉진요인으로 작용하고 있습니다.

감염병 발생률 증가와 효과적인 질병 관리 및 통제의 필요성이 증가하고 있는 것도 중요한 촉진요인입니다. 조류독감, 아프리카돼지열병, 개 파보바이러스와 같은 질병의 발생은 질병의 확산을 방지하고 경제적 손실을 최소화하기 위해 신속하고 정확한 진단의 중요성을 강조하고 있습니다. 수의학 분자진단학은 병원체 검출 및 감별을 위한 신뢰할 수 있는 솔루션을 제공하여 수의사가 적시에 적절한 개입을 할 수 있도록 돕습니다. 항균제 내성(AMR)에 대한 관심이 높아진 것도 시장 성장에 기여하고 있습니다. 분자진단은 내성 유전자를 식별하고 항생제의 적절한 사용을 유도하여 내성 발현의 위험을 줄일 수 있기 때문입니다. 또한, 특히 아시아태평양과 라틴아메리카 등 신흥 시장에서 동물 진단 실험실 및 연구기관의 확장은 시장 성장의 새로운 기회를 창출하고 있습니다. 이들 지역에서는 수의학 인프라 현대화와 첨단 진단 기술에 대한 접근성 개선에 투자하고 있어, 기술 혁신, 진화하는 의료 관행, 동물 및 공중보건에 대한 인식이 역동적으로 상호작용하면서 세계 수의학 분자진단 시장은 지속적으로 확대될 것으로 예상됩니다.

조사 대상 기업 예시(총 42건)

  • BIOMEDICA Medizinprodukte GmbH & Co.
  • Bioneer Corporation
  • HealthGene Corporation
  • Idexx Laboratories, Inc.
  • Novacyt Group
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.
  • Vca, Inc.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 24.11.01

Global Veterinary Molecular Diagnostics Market to Reach US$984.2 Million by 2030

The global market for Veterinary Molecular Diagnostics estimated at US$596.5 Million in the year 2023, is expected to reach US$984.2 Million by 2030, growing at a CAGR of 7.4% over the analysis period 2023-2030. Instruments & Software, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$342.8 Million by the end of the analysis period. Growth in the Kits & Reagents segment is estimated at 8.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$156.7 Million While China is Forecast to Grow at 11.0% CAGR

The Veterinary Molecular Diagnostics market in the U.S. is estimated at US$156.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$238.9 Million by the year 2030 trailing a CAGR of 11.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.9% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Veterinary Molecular Diagnostics Market - Key Trends & Growth Drivers Explored

Why Are Veterinary Molecular Diagnostics Revolutionizing Animal Health Management?

Veterinary molecular diagnostics have emerged as a transformative tool in animal healthcare, enabling precise and rapid detection of diseases at the molecular level. But what makes these diagnostic methods so essential in modern veterinary practices? Veterinary molecular diagnostics are advanced testing techniques that identify genetic material, such as DNA and RNA, from pathogens, tumors, or genetic disorders in animals. These tests include polymerase chain reaction (PCR), real-time PCR, next-generation sequencing (NGS), and microarrays, among others, which can detect and quantify pathogens, genetic mutations, or biomarkers with high sensitivity and specificity. By targeting the genetic basis of diseases, these diagnostics allow veterinarians to diagnose conditions early, often before clinical symptoms appear, providing a crucial window for timely intervention and treatment.

The demand for veterinary molecular diagnostics is driven by the growing prevalence of zoonotic diseases, the rising incidence of chronic and infectious conditions in animals, and the increasing focus on preventive healthcare. These diagnostics are widely used in the detection of infectious diseases such as parvovirus, feline leukemia, and bovine respiratory disease, as well as for genetic screening in breeding programs to prevent the transmission of hereditary disorders. Molecular diagnostics have also become indispensable in the field of oncology, where they are used to identify specific mutations and biomarkers that can guide targeted therapies for cancer treatment. Furthermore, the ability to differentiate between closely related pathogens and detect multiple pathogens in a single test has made molecular diagnostics a preferred choice in complex cases where traditional testing methods may fall short. As pet owners, livestock managers, and veterinarians seek more accurate and reliable diagnostic solutions, veterinary molecular diagnostics are poised to play an increasingly central role in animal health management.

How Are Technological Advancements Elevating the Performance of Veterinary Molecular Diagnostics?

The veterinary molecular diagnostics market has experienced significant technological advancements that have enhanced the precision, speed, and accessibility of these diagnostic tools. But what are the key innovations driving these developments? One of the most impactful advancements is the evolution of real-time PCR (qPCR) technology. qPCR has become a gold standard in veterinary diagnostics due to its ability to amplify and quantify DNA or RNA sequences in real-time, providing rapid and highly sensitive results. Modern qPCR systems are equipped with multiplexing capabilities, allowing the simultaneous detection of multiple pathogens or genetic markers in a single sample. This innovation has significantly reduced turnaround times and the need for multiple tests, enabling veterinarians to make quicker and more informed decisions. Additionally, the integration of automated sample preparation systems has streamlined the workflow, reducing the potential for human error and increasing the consistency and reliability of test results.

Another critical innovation is the advent of next-generation sequencing (NGS) technology, which has revolutionized the field of veterinary genomics. NGS allows for comprehensive genetic analysis by sequencing entire genomes or targeted regions of interest, providing insights into complex genetic traits, disease mechanisms, and microbial communities. This technology is being increasingly used in research and clinical settings for applications such as pathogen discovery, antimicrobial resistance monitoring, and cancer genotyping. The development of portable and point-of-care molecular diagnostic devices has further expanded the reach of these technologies, enabling veterinarians to conduct testing on-site, whether in clinics, farms, or field settings. These devices are designed to be user-friendly, requiring minimal training and infrastructure, making advanced molecular diagnostics accessible even in remote or resource-limited environments. Furthermore, advancements in bioinformatics and data analytics have enhanced the interpretation of molecular diagnostic results, allowing for more accurate and actionable insights. These technological innovations have collectively elevated the performance and utility of veterinary molecular diagnostics, making them indispensable tools for modern veterinary medicine.

What Market Trends Are Driving the Adoption of Veterinary Molecular Diagnostics Across Animal Healthcare?

Several emerging market trends are shaping the adoption of veterinary molecular diagnostics across the animal healthcare sector, reflecting the evolving needs and expectations of veterinarians, researchers, and pet owners. One of the most prominent trends is the increasing focus on preventive care and early disease detection. As pet owners and livestock managers become more aware of the benefits of early diagnosis, there is a growing demand for diagnostic tools that can detect diseases at the subclinical stage, before they become symptomatic or spread to other animals. Veterinary molecular diagnostics, with their high sensitivity and specificity, are well-suited for this purpose, allowing for the early identification of infectious agents, genetic disorders, and cancerous cells. This trend is particularly strong in the companion animal sector, where regular health screenings and wellness programs are becoming more common. The ability to detect genetic predispositions and infectious diseases early enables veterinarians to implement targeted preventive measures and develop personalized treatment plans, improving health outcomes and reducing the long-term costs of care.

Another key trend driving the adoption of veterinary molecular diagnostics is the rising prevalence of zoonotic diseases and the need for effective disease surveillance. Zoonotic diseases, which are transmitted between animals and humans, pose a significant public health risk, making early and accurate diagnosis essential for controlling outbreaks and preventing cross-species transmission. The COVID-19 pandemic has underscored the importance of robust disease surveillance systems, leading to increased investment in diagnostic infrastructure for both companion animals and livestock. Veterinary molecular diagnostics are playing a critical role in this effort by providing tools that can detect zoonotic pathogens rapidly and accurately, supporting efforts to track and control disease spread. This trend is particularly evident in regions with large livestock populations, such as North America and Europe, where molecular diagnostics are used to monitor diseases like avian influenza, bovine tuberculosis, and African swine fever. The growing demand for comprehensive disease surveillance and biosecurity measures is expected to continue driving the adoption of molecular diagnostics in both the public and private sectors, reinforcing their role as key instruments in animal health management.

What Factors Are Driving the Growth of the Global Veterinary Molecular Diagnostics Market?

The growth in the global veterinary molecular diagnostics market is driven by several factors, including advancements in diagnostic technology, increasing investment in animal healthcare, and rising awareness of zoonotic diseases. One of the primary growth drivers is the expanding pet population and the humanization of pets, where owners treat their animals as family members and are willing to invest in advanced healthcare services. This has led to a surge in demand for diagnostic tests that provide quick and accurate results, enabling early diagnosis and effective treatment. The development of user-friendly and automated molecular diagnostic platforms has made it easier for veterinary clinics and hospitals to incorporate these tests into their routine diagnostic offerings, further boosting market growth. The increasing use of molecular diagnostics in livestock management is another key growth driver, as farmers and producers seek to improve herd health, productivity, and disease control.

Another significant growth driver is the rising incidence of infectious diseases and the growing need for effective disease management and control. Outbreaks of diseases like avian influenza, African swine fever, and canine parvovirus have highlighted the importance of rapid and accurate diagnostics for preventing disease spread and minimizing economic losses. Veterinary molecular diagnostics provide a reliable solution for detecting and differentiating pathogens, enabling veterinarians to implement timely and targeted interventions. The growing focus on antimicrobial resistance (AMR) is also contributing to market growth, as molecular diagnostics can identify resistance genes and guide the appropriate use of antibiotics, reducing the risk of resistance development. Furthermore, the expansion of veterinary diagnostic laboratories and research institutions, particularly in emerging markets such as Asia-Pacific and Latin America, is creating new opportunities for market growth. As these regions invest in modernizing their veterinary infrastructure and improving access to advanced diagnostic technologies, the global veterinary molecular diagnostics market is poised for sustained expansion, driven by a dynamic interplay of technological innovation, evolving healthcare practices, and increasing awareness of animal and public health.

Select Competitors (Total 42 Featured) -

  • BIOMEDICA Medizinprodukte GmbH & Co., KG
  • Bioneer Corporation
  • HealthGene Corporation
  • Idexx Laboratories, Inc.
  • Novacyt Group
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.
  • Vca, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Veterinary Molecular Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Infectious Diseases in Companion and Livestock Animals Drives Demand for Veterinary Molecular Diagnostics
    • Increased Adoption of Molecular Diagnostic Techniques in Veterinary Clinics and Laboratories Expands Addressable Market
    • Rising Use of Molecular Diagnostics in Zoonotic Disease Surveillance Sets the Stage for Market Growth
    • Surge in Demand for Molecular Diagnostic Tests in Food Safety and Animal Health Monitoring Expands Market Opportunities
    • Growing Adoption of Molecular Diagnostics in Veterinary Oncology and Genetic Disease Testing Strengthens Business Case
    • Technological Advancements in Multiplex and High-Throughput Molecular Diagnostic Platforms Propel Market Expansion
    • Growing Use of Molecular Diagnostics in Animal Reproductive Health and Fertility Management Strengthens Market Growth
    • Surge in Use of Molecular Diagnostic Techniques in Wildlife and Conservation Medicine Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Veterinary Molecular Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Veterinary Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Veterinary Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Instruments & Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Instruments & Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Instruments & Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction (PCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Polymerase Chain Reaction (PCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Polymerase Chain Reaction (PCR) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for DNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for DNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for DNA Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals/Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals/Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Hospitals/Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Reference Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • JAPAN
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • CHINA
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • EUROPE
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Veterinary Molecular Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Veterinary Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • FRANCE
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • GERMANY
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Veterinary Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • INDIA
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: India 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: India 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: India 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Veterinary Molecular Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Veterinary Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Veterinary Molecular Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Veterinary Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • AFRICA
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제